SpIntellx is a Pittsburgh, PA-based scaling-stage company focused on the development of explainable AI-powered spatial analytics software platforms to decipher the complex cancer biology and accelerate innovation in precision pathology and spatial biology. SpIntellx's solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. At SpIntellx, we leverage the most advanced form of AI to get to the “why” and unravel complex cancer biology.